VKTX - Viking Therapeutics, Inc.

📈 Is growth accelerating? 3 metrics

Metric	Q3 FY2026 Sep 30, 2026 10-Q ↗	Q2 FY2026 Jun 30, 2026 10-Q ↗	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗	Q3 FY2019 Sep 30, 2019 10-Q ↗	Q2 FY2019 Jun 30, 2019 10-Q ↗	Q1 FY2019 Mar 31, 2019 10-Q ↗	Q4 FY2018 Dec 31, 2018 10-K ↗	Q3 FY2018 Sep 30, 2018 10-Q ↗	Q2 FY2018 Jun 30, 2018 10-Q ↗	Q1 FY2018 Mar 31, 2018 10-Q ↗	Q4 FY2017 Dec 31, 2017 10-K ↗	Q3 FY2017 Sep 30, 2017 10-Q ↗	Q2 FY2017 Jun 30, 2017 10-Q ↗	Q1 FY2017 Mar 31, 2017 10-Q ↗	Q4 FY2016 Dec 31, 2016 10-K ↗	Q3 FY2016 Sep 30, 2016 10-Q ↗	Q2 FY2016 Jun 30, 2016 10-Q ↗	Q1 FY2016 Mar 31, 2016 10-Q ↗	Q4 FY2015 Dec 31, 2015 10-K ↗	Q3 FY2015 Sep 30, 2015 10-Q ↗	Q2 FY2015 Jun 30, 2015 10-Q ↗	Q1 FY2015 Mar 31, 2015 10-Q ↗	Q4 FY2014 Dec 31, 2014 10-K ↗	Q3 FY2014 Sep 30, 2014 10-Q ↗	Q2 FY2014 Jun 30, 2014 10-Q ↗	Q1 FY2014 Mar 31, 2014 10-Q ↗	Q4 FY2013 Dec 31, 2013 10-K ↗
EPS Growth YoY (%)	-91.4% Weak ↑ Weak Improving Year-over-year change in earnings per share Optimal: > 10%	-89.7% Weak ↑ Weak Improving Year-over-year change in earnings per share Optimal: > 10%	-234.1% Weak ↑ Weak Improving Year-over-year change in earnings per share Optimal: > 10%	-334.4% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	-268.2% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	-190.0% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	-57.7% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	—	4.3% Caution ↑ Caution Improving Year-over-year change in earnings per share Optimal: > 10%	-5.3% Weak ↑ Weak Improving Year-over-year change in earnings per share Optimal: > 10%	-4.0% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	—	-9.5% Weak Weak Year-over-year change in earnings per share Optimal: > 10%	17.4% Good Good Year-over-year change in earnings per share Optimal: > 10%	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	12.5% Fair Fair Year-over-year change in earnings per share Optimal: > 10%	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Net Income Growth YoY (%)	-101.8% Weak ↑ Weak Improving Year-over-year change in net income	-95.3% Weak ↑ Weak Improving Year-over-year change in net income	-247.0% Weak ↑ Weak Improving Year-over-year change in net income	-345.2% Weak ↓ Weak Declining Year-over-year change in net income	-264.0% Weak ↓ Weak Declining Year-over-year change in net income	-194.7% Weak ↓ Weak Declining Year-over-year change in net income	-66.8% Weak ↓ Weak Declining Year-over-year change in net income	—	-10.7% Weak ↑ Weak Improving Year-over-year change in net income	-15.7% Weak ↑ Weak Improving Year-over-year change in net income	-40.1% Weak ↓ Weak Declining Year-over-year change in net income	—	-42.9% Weak ↓ Weak Declining Year-over-year change in net income	-10.3% Weak ↑ Weak Improving Year-over-year change in net income	-21.3% Weak ↓ Weak Declining Year-over-year change in net income	—	-19.1% Weak ↓ Weak Declining Year-over-year change in net income	-13.3% Weak ↑ Weak Improving Year-over-year change in net income	-14.9% Weak ↑ Weak Improving Year-over-year change in net income	—	-42.6% Weak ↑ Weak Improving Year-over-year change in net income	-60.7% Weak ↓ Weak Declining Year-over-year change in net income	-44.6% Weak → Weak Stable Year-over-year change in net income	-47.0% Weak ↑ Weak Improving Year-over-year change in net income	-62.1% Weak ↓ Weak Declining Year-over-year change in net income	-24.7% Weak ↑ Weak Improving Year-over-year change in net income	-96.7% Weak ↓ Weak Declining Year-over-year change in net income	-42.2% Weak ↓ Weak Declining Year-over-year change in net income	13.2% Fair ↑ Fair Improving Year-over-year change in net income	-15.0% Weak ↑ Weak Improving Year-over-year change in net income	-38.7% Weak ↓ Weak Declining Year-over-year change in net income	-28.3% Weak ↓ Weak Declining Year-over-year change in net income	-8.2% Weak ↓ Weak Declining Year-over-year change in net income	-29.0% Weak ↓ Weak Declining Year-over-year change in net income	32.0% Excellent ↑ Excellent Improving Year-over-year change in net income	-12.1% Weak ↑ Weak Improving Year-over-year change in net income	-60.2% Weak ↓ Weak Declining Year-over-year change in net income	-40.0% Weak ↓ Weak Declining Year-over-year change in net income	-45.6% Weak ↓ Weak Declining Year-over-year change in net income	28.4% Excellent ↓ Excellent Declining Year-over-year change in net income	19.6% Good ↓ Good Declining Year-over-year change in net income	53.0% Excellent ↑ Excellent Improving Year-over-year change in net income	37.2% Excellent ↑ Excellent Improving Year-over-year change in net income	N/M	-1709.2% Weak ↓ Weak Declining Year-over-year change in net income	65.5% Excellent Excellent Year-over-year change in net income	-2394.7% Weak Weak Year-over-year change in net income	—	—	—	—	—
FCF Growth YoY (%)	—	—	-111.2% Weak Weak Year-over-year change in free cash flow	—	—	—	-687.6% Weak Weak Year-over-year change in free cash flow	—	—	—	81.1% Excellent Excellent Year-over-year change in free cash flow	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—

💰 Are margins durable? 1 metrics

Metric	Q3 FY2026 Sep 30, 2026 10-Q ↗	Q2 FY2026 Jun 30, 2026 10-Q ↗	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗	Q3 FY2019 Sep 30, 2019 10-Q ↗	Q2 FY2019 Jun 30, 2019 10-Q ↗	Q1 FY2019 Mar 31, 2019 10-Q ↗	Q4 FY2018 Dec 31, 2018 10-K ↗	Q3 FY2018 Sep 30, 2018 10-Q ↗	Q2 FY2018 Jun 30, 2018 10-Q ↗	Q1 FY2018 Mar 31, 2018 10-Q ↗	Q4 FY2017 Dec 31, 2017 10-K ↗	Q3 FY2017 Sep 30, 2017 10-Q ↗	Q2 FY2017 Jun 30, 2017 10-Q ↗	Q1 FY2017 Mar 31, 2017 10-Q ↗	Q4 FY2016 Dec 31, 2016 10-K ↗	Q3 FY2016 Sep 30, 2016 10-Q ↗	Q2 FY2016 Jun 30, 2016 10-Q ↗	Q1 FY2016 Mar 31, 2016 10-Q ↗	Q4 FY2015 Dec 31, 2015 10-K ↗	Q3 FY2015 Sep 30, 2015 10-Q ↗	Q2 FY2015 Jun 30, 2015 10-Q ↗	Q1 FY2015 Mar 31, 2015 10-Q ↗	Q4 FY2014 Dec 31, 2014 10-K ↗	Q3 FY2014 Sep 30, 2014 10-Q ↗	Q2 FY2014 Jun 30, 2014 10-Q ↗	Q1 FY2014 Mar 31, 2014 10-Q ↗	Q4 FY2013 Dec 31, 2013 10-K ↗
FCF / Net Income (x)	0.75x Caution → Caution Stable Free cash flow relative to reported net income Optimal: > 1x	0.98x Caution ↑ Caution Improving Free cash flow relative to reported net income Optimal: > 1x	0.72x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	0.54x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	—	—	1.15x Fair Fair Free cash flow relative to reported net income Optimal: > 1x	0.88x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	—	—	0.22x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	—	—	—	1.26x Good Good Free cash flow relative to reported net income Optimal: > 1x	—	—	—	0.65x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	—	—	—	0.78x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	0.50x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	—	—	0.44x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	1.58x Excellent Excellent Free cash flow relative to reported net income Optimal: > 1x	—	—	0.64x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	0.51x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	—	—	—	0.97x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—

🎯 Is capital allocation efficient? 3 metrics

Metric	Q3 FY2026 Sep 30, 2026 10-Q ↗	Q2 FY2026 Jun 30, 2026 10-Q ↗	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗	Q3 FY2019 Sep 30, 2019 10-Q ↗	Q2 FY2019 Jun 30, 2019 10-Q ↗	Q1 FY2019 Mar 31, 2019 10-Q ↗	Q4 FY2018 Dec 31, 2018 10-K ↗	Q3 FY2018 Sep 30, 2018 10-Q ↗	Q2 FY2018 Jun 30, 2018 10-Q ↗	Q1 FY2018 Mar 31, 2018 10-Q ↗	Q4 FY2017 Dec 31, 2017 10-K ↗	Q3 FY2017 Sep 30, 2017 10-Q ↗	Q2 FY2017 Jun 30, 2017 10-Q ↗	Q1 FY2017 Mar 31, 2017 10-Q ↗	Q4 FY2016 Dec 31, 2016 10-K ↗	Q3 FY2016 Sep 30, 2016 10-Q ↗	Q2 FY2016 Jun 30, 2016 10-Q ↗	Q1 FY2016 Mar 31, 2016 10-Q ↗	Q4 FY2015 Dec 31, 2015 10-K ↗	Q3 FY2015 Sep 30, 2015 10-Q ↗	Q2 FY2015 Jun 30, 2015 10-Q ↗	Q1 FY2015 Mar 31, 2015 10-Q ↗	Q4 FY2014 Dec 31, 2014 10-K ↗	Q3 FY2014 Sep 30, 2014 10-Q ↗	Q2 FY2014 Jun 30, 2014 10-Q ↗	Q1 FY2014 Mar 31, 2014 10-Q ↗	Q4 FY2013 Dec 31, 2013 10-K ↗
Return on Invested Capital (%)	-25.1% Weak → Weak Stable Return earned on debt + equity capital invested Optimal: > 10%	-25.7% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-25.8% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-20.4% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-10.9% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-7.4% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-5.2% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-4.1% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-3.2% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-2.9% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-2.9% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	—	-5.8% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-4.9% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-12.1% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	—	-8.5% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-8.4% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-7.0% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	—	-5.0% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-5.5% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-4.7% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-3.6% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-3.1% Weak → Weak Stable Return earned on debt + equity capital invested Optimal: > 10%	-3.2% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-3.2% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-2.5% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-2.1% Weak → Weak Stable Return earned on debt + equity capital invested Optimal: > 10%	-2.6% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-1.8% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-1.9% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-1.9% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-3.9% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-5.2% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-26.0% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-166.5% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-59.8% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-52.0% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-36.7% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-25.2% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-22.1% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-44.7% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-41.8% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-25.5% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-11.9% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	1.3% Weak Weak Return earned on debt + equity capital invested Optimal: > 10%	1.3% Weak Weak Return earned on debt + equity capital invested Optimal: > 10%	—	—	—	—
Return on Capital (%) (%)	-19.1% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-25.4% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-27.0% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-23.0% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-13.3% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-9.0% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-6.4% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-5.1% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-3.9% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-3.6% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-3.5% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	—	-7.1% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-5.9% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-13.6% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	—	-9.7% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-9.7% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-8.3% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	—	-6.0% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-6.5% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-5.7% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-4.4% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-3.7% Weak → Weak Stable Operating profit relative to total assets Optimal: > 10%	-3.9% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-4.0% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-3.1% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-2.6% Weak → Weak Stable Operating profit relative to total assets Optimal: > 10%	-3.2% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-2.3% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-2.3% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-2.4% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-4.8% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-6.1% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-20.0% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-39.6% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-34.8% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-32.8% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-25.7% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-20.0% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-19.3% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-25.6% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-29.9% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-22.6% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-11.8% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-16.6% Weak Weak Operating profit relative to total assets Optimal: > 10%	-11.6% Weak Weak Operating profit relative to total assets Optimal: > 10%	—	—	—	—
Return on Common Equity (%) (%)	-31.1% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-307%)	-31.4% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-309%)	-31.5% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-310%)	-24.7% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-264%)	-12.7% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-185%)	-8.2% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-155%)	-5.4% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-136%)	-4.0% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-127%)	-2.7% Weak → Weak Stable Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-118%)	-2.4% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-116%)	-2.9% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-120%)	—	-6.1% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-141%)	-5.0% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-133%)	-14.6% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-197%)	—	-10.4% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-170%)	-10.6% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-170%)	-8.8% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-159%)	—	-6.2% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-141%)	-6.8% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-146%)	-5.9% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-139%)	-4.5% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-130%)	-3.7% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-124%)	-3.7% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-124%)	-3.6% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-124%)	-2.7% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-118%)	-2.0% Weak → Weak Stable Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-113%)	-2.7% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-118%)	-1.7% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-111%)	-1.8% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-112%)	-2.2% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-115%)	-4.8% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-132%)	-4.9% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-133%)	-30.3% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-302%)	-274.0% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-1927%)	-78.5% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-623%)	-69.2% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-561%)	-45.3% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-402%)	-37.3% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-348%)	-28.9% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-293%)	-62.2% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-514%)	-58.3% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-489%)	-35.7% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-338%)	-45.2% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-401%)	20.5% Excellent Excellent Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+37%)	-6.3% Weak Weak Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-142%)	—	—	—	—

⚖️ Is the balance sheet risky? 2 metrics

Metric	Q3 FY2026 Sep 30, 2026 10-Q ↗	Q2 FY2026 Jun 30, 2026 10-Q ↗	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗	Q3 FY2019 Sep 30, 2019 10-Q ↗	Q2 FY2019 Jun 30, 2019 10-Q ↗	Q1 FY2019 Mar 31, 2019 10-Q ↗	Q4 FY2018 Dec 31, 2018 10-K ↗	Q3 FY2018 Sep 30, 2018 10-Q ↗	Q2 FY2018 Jun 30, 2018 10-Q ↗	Q1 FY2018 Mar 31, 2018 10-Q ↗	Q4 FY2017 Dec 31, 2017 10-K ↗	Q3 FY2017 Sep 30, 2017 10-Q ↗	Q2 FY2017 Jun 30, 2017 10-Q ↗	Q1 FY2017 Mar 31, 2017 10-Q ↗	Q4 FY2016 Dec 31, 2016 10-K ↗	Q3 FY2016 Sep 30, 2016 10-Q ↗	Q2 FY2016 Jun 30, 2016 10-Q ↗	Q1 FY2016 Mar 31, 2016 10-Q ↗	Q4 FY2015 Dec 31, 2015 10-K ↗	Q3 FY2015 Sep 30, 2015 10-Q ↗	Q2 FY2015 Jun 30, 2015 10-Q ↗	Q1 FY2015 Mar 31, 2015 10-Q ↗	Q4 FY2014 Dec 31, 2014 10-K ↗	Q3 FY2014 Sep 30, 2014 10-Q ↗	Q2 FY2014 Jun 30, 2014 10-Q ↗	Q1 FY2014 Mar 31, 2014 10-Q ↗	Q4 FY2013 Dec 31, 2013 10-K ↗
Interest Coverage (x)	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	-200.21x Weak Weak Operating income divided by interest expense Optimal: > 5x	—	—	—	—	—	—	—	—	—	—	—	-13.08x Weak Weak Operating income divided by interest expense Optimal: > 5x	—	—	—	-81.42x Weak Weak Operating income divided by interest expense Optimal: > 5x	—
Net Debt (USD)	$-677.61M	$-125.75M	$-118.12M	$-165.81M	$-100.38M	$-33.88M	$-37.94M	$-26.68M	$-50.35M	$-43.91M	$-195.58M	$-55.52M	$-37.19M	$-69.52M	$-18.36M	$-36.63M	$-29.41M	$-16.23M	$-12.45M	$-26.37M	$-11.26M	$-8.83M	$-16.80M	$-29.12M	$-3.87M	$-18.79M	$-15.26M	$-8.38M	$-30.95M	$-19.12M	$-14.34M	$-24.78M	$-169.51M	$-34.61M	$-36.36M	$-8.99M	$-2.57M	$-3.39M	$-4.36M	$-3.08M	$-3.05M	$-5.16M	$-3.96M	$-768.55K	$-2.14M	$-9.50M	$-327.01K	$-755.86K	$-794.41K	$-891.48K	$-179.62K	$-179.62K

📊 What does each share earn? 6 metrics

Metric	Q3 FY2026 Sep 30, 2026 10-Q ↗	Q2 FY2026 Jun 30, 2026 10-Q ↗	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗	Q3 FY2019 Sep 30, 2019 10-Q ↗	Q2 FY2019 Jun 30, 2019 10-Q ↗	Q1 FY2019 Mar 31, 2019 10-Q ↗	Q4 FY2018 Dec 31, 2018 10-K ↗	Q3 FY2018 Sep 30, 2018 10-Q ↗	Q2 FY2018 Jun 30, 2018 10-Q ↗	Q1 FY2018 Mar 31, 2018 10-Q ↗	Q4 FY2017 Dec 31, 2017 10-K ↗	Q3 FY2017 Sep 30, 2017 10-Q ↗	Q2 FY2017 Jun 30, 2017 10-Q ↗	Q1 FY2017 Mar 31, 2017 10-Q ↗	Q4 FY2016 Dec 31, 2016 10-K ↗	Q3 FY2016 Sep 30, 2016 10-Q ↗	Q2 FY2016 Jun 30, 2016 10-Q ↗	Q1 FY2016 Mar 31, 2016 10-Q ↗	Q4 FY2015 Dec 31, 2015 10-K ↗	Q3 FY2015 Sep 30, 2015 10-Q ↗	Q2 FY2015 Jun 30, 2015 10-Q ↗	Q1 FY2015 Mar 31, 2015 10-Q ↗	Q4 FY2014 Dec 31, 2014 10-K ↗	Q3 FY2014 Sep 30, 2014 10-Q ↗	Q2 FY2014 Jun 30, 2014 10-Q ↗	Q1 FY2014 Mar 31, 2014 10-Q ↗	Q4 FY2013 Dec 31, 2013 10-K ↗
Revenue per Share (USD)	$0.00	$0.00	$0.00	—	$0.00	$0.00	$0.00	—	$0.00	$0.00	$0.00	—	$0.00	$0.00	$0.00	—	$0.00	$0.00	—	—	—	—	—	—	—	—	—	—	—	—	$0.00	—	$0.00	$0.00	$0.00	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Basic EPS, GAAP (USD)	$-1.55	$-1.10	$-1.37	$-1.39	$-0.81	$-0.58	$-0.41	$-0.32	$-0.22	$-0.20	$-0.26	—	$-0.23	$-0.19	$-0.25	—	$-0.21	$-0.23	—	—	—	—	—	—	—	—	—	—	—	—	$-0.07	—	—	—	$-0.08	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Free Cash Flow per Share (USD)	$-1.17	$-1.08	$-0.99	—	—	—	$-0.47	—	—	—	$-0.06	—	—	—	$-0.31	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	$-0.04	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Book Value per Share (USD)	$4.62	$3.50	$4.33	$5.57	$6.34	$7.08	$7.54	$7.89	$8.18	$8.31	$8.47	$3.48	$3.68	$3.86	$1.69	$1.86	$1.97	$2.15	$2.36	$2.58	$2.72	$2.88	$3.07	$3.34	$3.48	$3.60	$3.70	$3.83	$3.92	$4.00	$4.09	$4.15	$4.24	$2.31	$1.43	$0.38	$0.08	$0.24	$0.32	$0.39	$0.51	$0.66	$0.60	$0.90	$1.36	$1.78	$-4.64	$-3.69	—	—	—	—
Tangible Book Value per Share (USD)	$4.62	$3.50	$4.33	$5.57	$6.34	$7.08	$7.54	$7.89	$8.18	$8.31	$8.47	$3.48	$3.68	$3.86	$1.69	$1.86	$1.97	$2.15	$2.36	$2.58	$2.72	$2.88	$3.07	$3.34	$3.48	$3.60	$3.70	$3.83	$3.92	$4.00	$4.09	$4.15	$4.24	$2.31	$1.43	$0.38	$0.08	$0.24	$0.32	$0.39	$0.51	$0.66	$0.60	$0.90	$1.36	$1.78	$-4.64	$-3.69	—	—	—	—
Basic Weighted Avg Shares (shares)	118.05M	116.26M	115.57M	—	112.32M	112.13M	112.07M	—	110.91M	110.39M	103.46M	—	99.85M	99.01M	78.35M	—	76.51M	76.84M	—	—	—	—	—	—	—	—	—	—	—	—	71.76M	—	61.23M	52.77M	44.65M	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—

🏦 How resilient is the balance sheet? 2 metrics

Metric	Q3 FY2026 Sep 30, 2026 10-Q ↗	Q2 FY2026 Jun 30, 2026 10-Q ↗	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗	Q3 FY2019 Sep 30, 2019 10-Q ↗	Q2 FY2019 Jun 30, 2019 10-Q ↗	Q1 FY2019 Mar 31, 2019 10-Q ↗	Q4 FY2018 Dec 31, 2018 10-K ↗	Q3 FY2018 Sep 30, 2018 10-Q ↗	Q2 FY2018 Jun 30, 2018 10-Q ↗	Q1 FY2018 Mar 31, 2018 10-Q ↗	Q4 FY2017 Dec 31, 2017 10-K ↗	Q3 FY2017 Sep 30, 2017 10-Q ↗	Q2 FY2017 Jun 30, 2017 10-Q ↗	Q1 FY2017 Mar 31, 2017 10-Q ↗	Q4 FY2016 Dec 31, 2016 10-K ↗	Q3 FY2016 Sep 30, 2016 10-Q ↗	Q2 FY2016 Jun 30, 2016 10-Q ↗	Q1 FY2016 Mar 31, 2016 10-Q ↗	Q4 FY2015 Dec 31, 2015 10-K ↗	Q3 FY2015 Sep 30, 2015 10-Q ↗	Q2 FY2015 Jun 30, 2015 10-Q ↗	Q1 FY2015 Mar 31, 2015 10-Q ↗	Q4 FY2014 Dec 31, 2014 10-K ↗	Q3 FY2014 Sep 30, 2014 10-Q ↗	Q2 FY2014 Jun 30, 2014 10-Q ↗	Q1 FY2014 Mar 31, 2014 10-Q ↗	Q4 FY2013 Dec 31, 2013 10-K ↗
Working Capital (USD)	$839.10M	$407.91M	$501.88M	$638.93M	$712.64M	$795.04M	$846.45M	$879.80M	$910.96M	$920.63M	$933.56M	$348.09M	$367.89M	$385.89M	$133.82M	$145.09M	$151.09M	$165.00M	$182.03M	$201.75M	$212.93M	$224.79M	$236.95M	$243.97M	$253.42M	$261.56M	$267.90M	$276.72M	$283.06M	$288.02M	$294.22M	$297.58M	$301.87M	$140.15M	$72.39M	$13.19M	$1.91M	$6.54M	$11.29M	$7.50M	$9.55M	$12.57M	$10.24M	$13.22M	$13.21M	$17.39M	$-27.35M	$-21.74M	—	—	—	—
Total Equity (USD)	$588.60M	$408.32M	$501.92M	$639.06M	$713.03M	$795.46M	$846.92M	$880.28M	$911.45M	$920.98M	$933.89M	$348.42M	$368.24M	$386.12M	$134.06M	$145.32M	$151.28M	$165.23M	$182.27M	$201.88M	$213.12M	$224.97M	$237.22M	$244.34M	$253.79M	$261.95M	$268.28M	$277.12M	$283.49M	$288.35M	$294.57M	$297.75M	$302.05M	$140.36M	$72.63M	$13.46M	$2.23M	$6.59M	$7.55M	$8.04M	$10.22M	$12.79M	$5.77M	$8.72M	$13.27M	$17.39M	$-27.84M	$-22.13M	—	—	—	—

📋 What is driving earnings? 3 metrics

Metric	Q3 FY2026 Sep 30, 2026 10-Q ↗	Q2 FY2026 Jun 30, 2026 10-Q ↗	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗	Q3 FY2019 Sep 30, 2019 10-Q ↗	Q2 FY2019 Jun 30, 2019 10-Q ↗	Q1 FY2019 Mar 31, 2019 10-Q ↗	Q4 FY2018 Dec 31, 2018 10-K ↗	Q3 FY2018 Sep 30, 2018 10-Q ↗	Q2 FY2018 Jun 30, 2018 10-Q ↗	Q1 FY2018 Mar 31, 2018 10-Q ↗	Q4 FY2017 Dec 31, 2017 10-K ↗	Q3 FY2017 Sep 30, 2017 10-Q ↗	Q2 FY2017 Jun 30, 2017 10-Q ↗	Q1 FY2017 Mar 31, 2017 10-Q ↗	Q4 FY2016 Dec 31, 2016 10-K ↗	Q3 FY2016 Sep 30, 2016 10-Q ↗	Q2 FY2016 Jun 30, 2016 10-Q ↗	Q1 FY2016 Mar 31, 2016 10-Q ↗	Q4 FY2015 Dec 31, 2015 10-K ↗	Q3 FY2015 Sep 30, 2015 10-Q ↗	Q2 FY2015 Jun 30, 2015 10-Q ↗	Q1 FY2015 Mar 31, 2015 10-Q ↗	Q4 FY2014 Dec 31, 2014 10-K ↗	Q3 FY2014 Sep 30, 2014 10-Q ↗	Q2 FY2014 Jun 30, 2014 10-Q ↗	Q1 FY2014 Mar 31, 2014 10-Q ↗	Q4 FY2013 Dec 31, 2013 10-K ↗
Sales/Revenue/Turnover (USD)	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	—	$0.00	$0.00	$0.00	—	$0.00	$0.00	$0.00	—	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	—
Net Income, GAAP (USD)	$-183.19M	$-128.02M	$-158.32M	$-157.66M	$-90.79M	$-65.56M	$-45.63M	$-35.42M	$-24.94M	$-22.25M	$-27.36M	—	$-22.53M	$-19.23M	$-19.53M	—	$-15.77M	$-17.43M	$-16.10M	—	$-13.24M	$-15.38M	$-14.01M	$-10.95M	$-9.29M	$-9.57M	$-9.69M	$-7.45M	$-5.73M	$-7.67M	$-4.92M	$-5.24M	$-6.60M	$-6.67M	$-3.55M	$-4.08M	$-6.10M	$-5.17M	$-5.22M	$-3.64M	$-3.81M	$-3.69M	$-3.59M	$-5.09M	$-4.74M	$-7.87M	$-5.71M	$1.39M	$-261.80K	$-22.78M	$-228.94K	—
Operating Cash Flow (USD)	$-138.19M	$-125.17M	$-113.98M	$-85.29M	—	—	$-52.33M	$-31.18M	—	—	$-6.13M	—	—	—	$-24.64M	—	—	—	$-10.53M	—	—	—	$-10.88M	$-5.49M	—	—	$-4.30M	$-11.74M	—	—	$-3.15M	$-2.68M	—	—	—	$-3.95M	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—

Viking Therapeutics, Inc.

Analytical Summary

52-Year Financial Trajectory

Bullish Indicators

Bearish Risks

Health Breakdown

Statement lens

Benchmark Lens

Signals

Percentile Rankings

Peer Comparison

Compare VKTX with peers